Ligand Pharmaceuticals In shares owned by Citadel Advisors
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.2M | 31k | 71.42 |
| 2023-09-30 | $2.7M | 46k | 59.92 |
| 2023-06-30 | $1.3M | 18k | 72.10 |
| 2023-03-31 | $5.8M | 79k | 73.56 |
| 2022-12-31 | $11M | 162k | 66.80 |
| 2022-06-30 | $1.3M | 14k | 89.29 |
| 2022-03-31 | $1.7M | 15k | 112.37 |
| 2021-12-31 | $4.1M | 27k | 154.40 |
| 2021-09-30 | $6.4M | 46k | 139.25 |
| 2021-06-30 | $4.5M | 35k | 131.18 |
| 2021-03-31 | $19M | 122k | 152.45 |
| 2020-12-31 | $30M | 303k | 99.45 |
| 2020-09-30 | $25M | 265k | 95.32 |
| 2020-06-30 | $17M | 152k | 111.85 |
| 2020-03-31 | $19M | 266k | 72.72 |
| 2019-12-31 | $18M | 176k | 104.27 |
| 2019-09-30 | $17M | 174k | 99.53 |
| 2019-06-30 | $13M | 112k | 114.16 |
| 2019-03-31 | $28M | 226k | 125.71 |
| 2018-12-31 | $21M | 154k | 135.71 |
| 2018-09-30 | $16M | 57k | 274.69 |
| 2018-06-30 | $13M | 64k | 207.19 |
| 2018-03-31 | $6.5M | 39k | 165.49 |
| 2017-12-31 | $2.1M | 16k | 136.77 |
| 2017-09-30 | $2.2M | 17k | 136.17 |
| 2017-06-30 | $1.5M | 13k | 121.46 |
| 2017-03-31 | $890k | 8.4k | 105.92 |
| 2016-12-31 | $1.7M | 17k | 101.59 |
| 2016-09-30 | $2.9M | 28k | 102.06 |
| 2015-12-31 | $207k | 1.9k | 108.66 |
| 2015-03-31 | $271k | 3.5k | 77.08 |
| 2014-12-31 | $244k | 4.6k | 53.18 |
| 2014-09-30 | $141k | 3.0k | 47.08 |
| 2014-06-30 | $174k | 2.8k | 62.37 |
| 2014-03-31 | $2.1M | 32k | 67.24 |
| 2013-12-31 | $247k | 4.7k | 52.49 |
| 2013-09-30 | $1.7M | 39k | 43.29 |